(Press-News.org) Every year 18 million people die from cardiovascular disease. Making it the deadliest disease in the world. Currently studies focus mainly on the heart, leaving the influence of vascular disease on these large numbers of deaths often out of sight. Despite vascular disorders being a trustworthy indicator for death from heart disease.
VASCUL-AID, a large European study led by Amsterdam UMC, will therefore focus on using AI to predict the worsening of vascular disease in people with an aortic aneurysm or peripheral arterty disease. In a quarter of people, the aforementioned conditions lead to heart problems or even a stroke. Today, VASCUL-AID launches thanks to a Horizon grant worth 6.4 million euros.
Thinking outside of the Heart
Kak Khee Yeung, vascular surgeon Amsterdam UMC and leader of European research: “Our vessels are an important part of the cardiovascular system that keeps people alive. Once you have a vascular disorder such as an aneurysm, we see that the aggravation of these diseases also increases the chance that you will eventually die from another cardiovascular disease. This indicates to us that we also need to investigate how we can stop these conditions that seem to occur outside the heart, but that do affect the functioning of the cardiovascular system.”
“At the moment it isn't possible to predict the course of aneurysm or of peripheral artery disease. People live in uncertainty about how their disease will develop and this results in many hospital visits and treatments. We would like to identify and isolate people with a high risk of their condition worsening from the large group in order to develop a more specific treatment plan. VASCUL-AID should make this possible,” says Yeung.
Identifying a high-risk vascular patient with AI
VASCUL-AID will unite partners across Europe to develop infrastructure in which data from patients with aneurysms and peripheral artery disease can be monitored. Six clinics across Europe, including Oxford University, will actively collect data from these patients. Using genetic data and imaging studies, as well as looking at protein profiles in blood and medication use. This will then be combined with existing databases and biobanks.
Patients will also gather their own data. An app has been developed that will gather data from telephones and wearable device relating to, for example, daily activity and quality of life as well as their heart rate.
“The markers that only characterize the high-risk group must be discovered from all the data. By using (AI) techniques, we will analyze all this data in order to subsequently identify the patients who are at the highest risk of worsening cardiovascular disease. They can then be helped earlier by medication adjustments or earlier surgical treatment.”
VASCUL-AID is one of the largest European studies using AI in cardiovascular disease to develop a personalized treatment plan. Special attention within the research will also be given to the development of reliable AI tools that can actually be used in the workplace.
END
Amsterdam UMC leads an AI-powered hunt for high-risk vascular patients
2023-05-04
ELSE PRESS RELEASES FROM THIS DATE:
Chimpanzees combine calls to communicate new meaning
2023-05-04
Similar to humans, chimpanzees combine vocalizations into larger communicatively meaningful structures. UZH researchers suggest that this ability might be evolutionarily more ancient than previously thought.
A key feature of human language is our ability to combine words into larger compositional phrases i.e. where the meaning of the whole is related to the meaning of the parts. Where this ability came from or how it evolved, however, is less clear.
Chimpanzees, our closest-living relative, are known to produce a number of different vocalizations to manage their ...
In first in-utero brain surgery, doctors eliminated symptoms of dangerous condition
2023-05-04
Research Highlights:
Using ultrasound guidance, researchers successfully repaired a potentially deadly vascular malformation, called vein of Galen malformation, deep in the brain of a fetus before birth. The malformation, which has massively high blood flow, often leads to heart failure, severe brain injury or possibly death soon after birth.
The first in-utero embolization repair was successfully performed on a fetus at 34 weeks and 2 days gestational age. Fetal ultrasound showed an immediate drop in abnormal blood flow through the ...
Team performs first-of-its-kind, in-utero procedure to fix deadly vascular malformation
2023-05-04
In a first, a team from Brigham and Women’s Hospital and Boston Children’s Hospital successfully treated an aggressive vascular malformation in an infant’s brain before birth, avoiding potentially fatal symptoms after delivery.
Collaborating researchers and clinicians from Boston Children’s Hospital and Brigham and Women’s Hospital have prevented a deadly developmental condition by treating an aggressive vascular malformation in an infant’s brain before birth. The case, which is the first-ever, in-utero cerebrovascular surgery in the United States, ...
Indigenous people in South America are twice as likely to die from wildfires
2023-05-04
A new study, published in IOP Publishing’s journal Environmental Research: Health, reveals that Indigenous people in the Amazon Basin are twice as likely to die prematurely from smoke exposure due to wildfires than the broader South American population. Regions in Peru, Bolivia and Brazil are identified as particular hotspots for smoke exposure, with mortality rates rising to as high as 6 times that of the general population.
The results show that smoke from wildfires in South America account for approximately 12,000 premature deaths every year from 2014 to 2019, with ...
Restricting flavored e-cigarettes may reduce their use among teens and young adults: Study
2023-05-04
PISCATAWAY, NJ—Getting many adolescents and young adults to stop using e-cigarettes may be as simple as doing away with flavored versions of the product, according to new research in the Journal of Studies on Alcohol and Drugs. This study suggests that a large majority of current users may discontinue their use if the product became available in the tobacco version only.
“The restriction of the availability for certain e-cigarette e-liquid flavors has been considered by various regulatory ...
Alumna named BioOne Ambassador for doctoral work in biological sciences
2023-05-04
Chelsea Kross, a University of Arkansas alumna in biological sciences, earned a 2023 BioOne Ambassador award for her submission “Not all frogs can make it in the city: Using the landscape for targeted conservation,” which summarized research done while working toward her Ph.D.
The award recognizes early career researchers in biological, ecological and environmental sciences who demonstrate creative approaches to science communication.
“Communicating complex research is critically important to fostering public understanding and support for the sciences,” said Lauren Kane, president and CEO of BioOne. “The 2023 BioOne ...
Remote aerobic walking exercise training feasible for improving cognitive processing speed in persons with multiple sclerosis
2023-05-04
East Hanover, NJ. May 3, 2023 – Results of a pilot study funded by Kessler Foundation showed that remote aerobic walking exercise training is a feasible and highly promising method for improving cognitive processing speed impairment in fully ambulatory persons with multiple sclerosis (MS). The findings of this single-blind randomized control trial support the design of a randomized, controlled trial in large sample of persons with MS
The study, titled "Feasibility of Remotely Delivered and Supported Aerobic Walking Exercise Training for Cognitive Processing Speed Impairment in Fully Ambulatory Persons with Multiple Sclerosis," (doi: ...
Offering genetic testing at the point of care may increase uptake
2023-05-04
Genetic testing for hereditary cancers, such as breast, colon, pancreatic, and ovarian cancer, helps at-risk individuals understand their familial risk for these diseases and make informed decisions about next steps in care. But fewer than 20 percent of at-risk patients utilize this testing, and even fewer engage in genetic counseling after referral, often due to clinical workflow challenges or barriers to care.
Amid national efforts to increase access to genetic testing, a new study led by a Boston University School of Public Health researcher has identified a streamlined approach in clinical settings that may help advance ...
Early life abuse may be linked to greater risk of adult premature death
2023-05-04
Physical and sexual abuse in childhood and adolescence could be associated with a greater risk of adult premature death (before age 70), finds research published by The BMJ today.
This study extends and refines the existing evidence in this area, and highlights the importance of providing trauma informed care for those who have experienced child abuse, say the researchers.
Early life abuse is a global public health issue because it substantially contributes to child death and a range of long term consequences during adulthood. However, the association of childhood or adolescent abuse with total and cause specific premature death during adulthood ...
New study finds no increased risk of menstrual changes after COVID-19 vaccination
2023-05-04
A Swedish study of nearly 3 million women published by The BMJ today finds no evidence of an increased risk of menstrual changes after covid-19 vaccination.
Weak and inconsistent associations were found between covid-19 vaccination and contact with healthcare for postmenopausal bleeding and were even less consistent for menstrual disturbance and premenstrual bleeding.
These findings do not provide any substantial support for a causal association between covid-19 vaccination and diagnoses related to ...